Skip to main content
  • Medicaid Provider Alert: Provider revalidation has begun and those not completing the process risk disenrollment.  Check your account now to learn when your revalidation is due. More information here.
Elizabeth M. Whitehorn, Director

Drugs and Therapeutics (D & T) Committee Meeting Results for June 11, 2014

Drug Name Review Type Committee Recommendation Prior Approval Status � Final Determination
Vimizim New Drug Initial Review Require Prior Approval Prior Approval Required
Aerospan HFA New Drug Initial Review Require Prior Approval Prior Approval Required
Farxiga New Drug Initial Review Require Prior Approval Prior Approval Required